臨床現場における卵巣癌患者に対するニラパリブの研究

基本情報

NCT ID

NCT05021562

ステータス

実施中（募集終了）

試験のフェーズ

-

試験タイプ

観察

目標被験者数

354

治験依頼者名

Takeda

概要

The main aim of this study is to check for side effects from treatment with niraparib. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. During the study, participants with ovarian cancer will take capsules of niraparib (Zedula) once a day according to their clinic's standard practice. The study doctors will check for side effects from niraparib for 1 year after treatment starts.

対象疾患

介入

依頼者（Sponsor）